alexa Potential Application of Gold Nanostructures in Photodynamic Therapy | Open Access Journals
ISSN: 2157-7439
Journal of Nanomedicine & Nanotechnology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Potential Application of Gold Nanostructures in Photodynamic Therapy

Hemant Kumar1*, Arvind Kumar2, Devendra Kumar Gangwar3, Prabin Kumar4, Gajendra Singh5 and Udit Soni6

1University of Hyderabad, School of Chemistry, Hyderabad -500046, India

2Department of Zoology, Bareilly College Bareilly, Bareilly, M. J. P. Rohilkhand University, Bareilly-23001, India

3Department of Chemistry, Vardhaman College, M. J. P. Rohilkhand University, Bijnor-246701, India

4Department of Chemistry, Sri Guru Tegh Bahadur Khalsa College, University of Delhi, Delhi-07, India

5Department of Chemistry, Deshbandhu College, University of Delhi, Delhi-19, India

6Department of Biotechnology, Teri University, Vasant Kunj, New Delhi-70, India

*Corresponding Author:
Hemant Kumar
University of Hyderabad
School of Chemistry, Hyderabad -500046, India
Tel: 91403010500
E-mail: [email protected]

Received Date: December 13, 2015 Accepted Date: Janaury 06, 2016 Published Date: January 25, 2016

Citation: Kumar H, Kumar A, Gangwar DK, Kumar P, Singh G, et al. (2016) Potential Application of Gold Nanostructures in Photodynamic Therapy. J Nanomed Nanotechnol 7:349. doi:10.4172/2157-7439.1000349

Copyright: © 2016 Kumar H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Nanotechnology

Abstract

In this manuscript we report the synthesis of gold nanostructures (G2) via seed-mediated growth method using CTAB as the surfactant, their size and morphology have been elucidated by TEM and DLS. The UV-visible absorption spectra of G2NPs showed a more intense peak at 680 nm and less intense peak at 520 nm indicating, formation of gold nanorods in majority. In case of G2 nanostructures the longitudinal LSPR peak could be tunable as a function of their aspect ratio. The gold nanostructures conjugated with a photosensitizer (G2-PS NPs) were applied in Photodynamic Therapy (PDT). These G2-PS NPs stably-dispersed in aqueous medium and were characterized by optical studies. Cell viability studies demonstrated that only PS conjugated NPs (G2-PS NPs) could only generate cytotoxic singlet oxygen. The results indicate the promise of G2-PS NPs as delivery agents in photodynamic therapy

Keywords

G2; TEM; EDX; XRD; PDT

Introduction

Nanomedicine has progressed from being simple monodiagnostic or monotherapeutic platform to more complex applications such as multimodal diagnostics, externally activated therapy, and theranostic. Inorganic nanomaterials have played a major part in the latest developments owing to their stability, biological inertness, facile chemistry and certain unique properties at nanoscale.

The important aspect is the Light activated therapy which is also known as photodynamic therapy (PDT) is a noninvasively technique known for its minimal toxicity in the management and treatment of cancer and several non-malignant diseases [1-3]. It involves direct (topical) or systemic administration of a photosensitizer (PS) drug, which produces reactive singlet oxygen (1O2) species when irradiated with light of appropriate wavelength (visible or NIR). The cytotoxic singlet oxygen is basically responsible for PDT effects. Due to the short half-life and limited diffusion distance (0.1 μm) of singlet oxygen in aqueous media, PDT effect remains localized at the irradiated (diseased) site, avoiding damage to surrounding healthy cells/tissues [4-6]. Although conceptually straightforward, effective PDT process is fraught with several drawbacks. One of the major drawbacks is that most PS drugs are hydrophobic in nature, which limits their proper biodistribution and pharmacokinetics [7-10]. This drawback can be overcome if the PS drugs are attached with nanosized carriers for better aqueous dispersion and efficient PDT action. Thus both catalysis and light activated therapy are surface phenomenon associated with size and morphology of the nanostructures.

Herein, we have synthesized of G2 NPs, conjugated with a PS molecule, and investigated whether nano-conjugation can enhance the singlet oxygen photogeneration efficacy of the PS. The PS molecule used here is 2-diazo-3-oxo-5, 10,15,20-tetraphenylchlorin [11-15].

Materials

Cetyltrimethylammonium bromide (CTAB), Hydrogen tetrachloroaurate(III) Trihydrate (HAuCl4.3H2O), Silver nitrate (AgNO3), L-ascorbic acid, Hydrochloric acid (HCl) solution (1.0 mol/L), Sodium borohydride (NaBH4), were all purchased from Alfa Aesar, 2,9-dimethyl(1,10-phenanthroline), 3-(4,5-dimethylthiazol-2- yl), 5-diphenyltetrazolium bromide (MTT) reagent, fetal bovine serum (FBS), Phosphate buffer saline (PBS), Dulbecco’s modified eagle’s medium (DMEM), Penicillin/Streptomycin, and Amphotericin-B and 9,10-anthracenediyl-bis(methylene) Dimalonic acid (ABMDMA) was purchased from Sigma-Aldrich.

Methods

Preparation of gold nanorods (G2)

Synthesis of seed solution: The gold seeds were prepared as described by Nikoobakht et al. [15]. In a typical reaction, 10 mL aqueous solution of CTAB (0.1 M) was mixed with 200 μL of aqueous gold precursor HAuCl4.3H2O (25 mM). Then, to this solution 600 μL of ice-cold aqueous NaBH4 solution (0.01 M) was quickly added. This leads to the controlled reduction of gold precursor into gold nanoseeds. After that, the seed solution was stirred for 2 minutes and kept at room temperature.

Seed mediated growth of G2: The nanogold growth solution was prepared by adding of 200 μL HAuCl4.3H2O (25 mM) to 10 mL DDW containing 0.1 M CTAB. Then, 150 μL ascorbic acid solution of (0.1 M), along with a specific amount of AgNO3 and HCl were added to this solution separately. The amount of water was added to give a final mixture volume of 10 mL. In the final mixture, the concentrations of CTAB, HAuCl4 and L-ascorbic acid were fixed at 0.1 M, 0.5 mM.

The AgNO3 concentration was varied from 0.06 mM and the HCl concentration from 0.01 M. The colorless growth solution was kept in a room temperature, after 30 minutes and 10 μL of seed solution was added to it. The resulting mixtures were left undisturbed for 20 min allowing seed-mediated GNPs formation to go to completion [12-14].

Formation of electrostatic conjugates of PS with G2 (PS-G2): The PS-G2 conjugates were formed by reaction of PS and G2 with in aqueous phase. The positive charges on the surface of G2 NPs were electrostatically-reacted with the negative charge present in PS. Here, 50 μL aqueous dispersion of PS (1 mg/mL) was added to a 1 mL of G2 solution (10 mg/mL in H2O), and mixed with shaking at room temperature for 2 minutes [3]. After formation of the PS-nanoparticle conjugates, they were separated from the free PS via centrifugation separation and washing in the aqueous medium.

Characterization

The sizes and morphology of nanostructures were determined via transmission electron microscopy (TEM) EDX and SAED using a TECNAI G2-30 U TWIN TEM instrument (FEI, Eindhoven, The Netherlands) with an acceleration voltage of 300 kV. The size of the nanostructures was further analyzed by dynamic light scattering (DLS) measurements, using a NANO-ZS series MALVERN ZETASIZER instrument. High resolution powder X-ray diffraction (XRD) was used to analyze the phase composition of the nanostructures, using a Brukar D8 Discover x-ray spectrometer, over the 2θ range from 20º–75º at rate of 2.58/min, using Cu-Kα radiation (λ= 1.54060 Å). The optical properties (UV-visible absorption and fluorescence emission spectra) of the gold nanostructures, drug, dye and photosensitizer samples were recorded using a Shimadzu UV-1601 spectrophotometer (Shimadzu, Kyoto, Japan) and a Cary Eclipse fluorescence spectrometer (Varian, Palo Alto, CA), respectively.

Detection of singlet oxygen generation by photosensitizer via photobleaching of ABMDMA

Photo-induced singlet oxygen generation was determined by photobleaching of the chemical probe 9, 10-anthracenediyl-bis (methylene) dimalonic acid (ABMDMA). ABMDMA is a water soluble derivative of anthracene that can be photobleached by singlet oxygen to its corresponding endoperoxide. The reaction was monitored spectrophotometrically by recording the decrease in optical den density at 400 nm (corresponding to the absorption λmax of ABMDMA). In a typical experiment, 0.40 μM of the sodium salt of ABMDMA in water was mixed with a mixture of photosensitizer (PS) and GNPs to give a final concentration of 2 μM for PS. The control experiment used 0.40 μM of the sodium salt of ABMDMA in water without any PS-GNPs mixture added. The solution was irradiated in an open quartz cuvette with continuous stirring. The absorbance measurements followed by irradiation were carried out every 10 min. A 450 W xenon-mercury lamp was used as the light source [15].

Results and Discussions

G2 NPs were prepared using seed-mediated growth methods. The G2 nanostructures have been synthesized in 20 nm diameter with some polydispersity, shown by TEM (Figure 1). XRD spectrum of gold nanostructures, showed diffraction peaks of 111, 200 and 220 (Figure 2), which match the characteristic peaks of inverse spinel oxide and the diffraction peaks delineate face-centered lattice (FCC) unit cells for the nanostructures (JCPDS 04-0785).

nanomedicine-nanotechnology-nanostructures

Figure 1: TEM images of G2 showing average at scale 20 nm gold nanostructures.

nanomedicine-nanotechnology-diffraction

Figure 2: The powder X-ray diffraction of gold nanostructures.

The UV-vis absorption spectra of aqueous dispersed G2 shown in Figures 3 and 4, corresponds to the LSPR phenomenon. Two peaks were observed for the G2, the first peak (transverse peak) at 520 nm, and the second one (longitudinal peak) at of 680 nm, which indicates that gold nanorods were formed as major component.

nanomedicine-nanotechnology-spectra

Figure 3: The Absorbance spectra of gold nanostructures.

nanomedicine-nanotechnology-Absorbance

Figure 4: Absorbance spectra of PS in water solution (inset: expanded view of the long wavelength ‘Q’ bands of the PS).

Use of the gold nanorods in PDT

Gold nanostructures can also be used as a drug carrier in photodynamic therapy (PDT) of cancer [15]. PDT occurs when photoexcited molecules (called photosensitizers or PS) transfer their excess energy to molecular oxygen, leading to the formation of highly toxic and reactive oxygen species (ROS) such as singlet oxygen which can kill cancer cells when targeted at cancer sites. The UV-vis spectra of PS was taken in water, which showed characteristic absorption peaks at 438, 525, 567, 605 and 669 nm.

We investigated the photogeneration of singlet oxygen by G2-PS NPs by studying the singlet oxygen mediated bleaching of the dye ABMDMA [15,16]. The reaction was studied by measuring the time dependent decrease in absorption of ABMDMA at 400 nm (λmax for ABMDMA) (Figure 5). When absorption spectra of PS and ABMDMA were taken individually no change in λmax were observed, when PS has been taken with ABMDMA down to 50% decrease in λmax was observed, but with G2-PS NPs λmax down to 30%. These absorption studies revealed that more cytotoxic singlet oxygen was generated with photosensitizer conjugated gold nanostructures and they can show promising therapeutic activity in light activated therapy (Figure 5).

nanomedicine-nanotechnology-results

Figure 5: Combined results for all the three systems, showing decrease of OD at 400 nm (absorption maxima of ABMDMA) as a function of laser irradiation time.

In vitro toxicity

For cell viability study human lung cancer cells A-549 grown in DMEM media were used, supplemented with 10% fetal bovine serum (FBS), 1% antibiotic penicillin/streptomycin, and 1% antifungal amphotericin B. Approximate 1,50,000 cells/1 mL fresh media were added to each well of a sterilized 24-well plate to analyse cell viability upon treatment with various nanoparticles, and transferred back to the incubator and overnight growth, cells seeded in 24-well plates at a confluence of about 40%. The following samples were added per well in triplicates: (a) free PS (0.15 μM), (b) G2 NPs (25 μg/ml), and (c) G2-PS NPs (0.15 μM PS conjugated on 25 μg/ml of G2 NPs). The two plates were then kept in incubator for 24 hours, then the cells were rinsed three times with sterile PBS and 500 μL fresh medium per well was added. One of the plates was immediately kept in incubator (no light irradiation). The other plate was first exposed to a 635 nm laser light (10 mins in each well) using diode laser with output power of 20 mW, and then returned to the incubator. After further overnight incubation, their viability was analysed by the MTT method [16-18]. The experiment was carried out in triplicates. Results shown in Figure 6 revealed that G2-PS killed upto 50% cancer cells on laser irradiation and without irradiation all cancer cells remains live, while G2 and PS both did not affect the cancer cells with or without irradiation (Figure 6).

nanomedicine-nanotechnology-Placebo

Figure 6: Percentage of cell survival of A-549 cells, after treatment with Placebo nanoparticles (G2 NPs), free PS (PS) and PS-Conjugated G2 nanoparticles (G2-PS NPs), with (light) and without (dark) subsequent irradiation with 630 nm laser light.

Conclusion

In this paper, we have discussed is microemulsion mediated process for the synthesis of gold nanostructures (G2). Characterization methods such as TEM, XRD and absorption measurements confirmed the formation of G2 nanostructures. The G2 also have shown promise as drug carriers in PDT.

Acknowledgements

We are grateful to University of Hyderabad, School of Chemistry, for providing R&D Grant to support this study. We thank Dr. Udit Soni for their help related to research work. Grant number is RC/2015/9435 (DBC-304) financial supported.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • Nano Congress for Next Generation
    August 31-September 01, 2017 Brussels,Belgium
  • Graphene & 2D Materials
    September 14-15, 2017 Edinburgh, Scotland
  • Graphene & 2D Materials
    November 6-7, 2017 Frankfurt, Germany
  • World Congress on Nanoscience and Nano Technology
    October 16-17, 2017 Dubai, UAE
  • World Medical Nanotechnology Congress
    October 18-19, 2017 Osaka, Japan
  • Nanoscienceand Molecular Nanotechnology
    Nov 06-08, 2017 Frankfurt, Germany

Article Usage

  • Total views: 7897
  • [From(publication date):
    February-2016 - Jul 28, 2017]
  • Breakdown by view type
  • HTML page views : 7829
  • PDF downloads :68
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords